Nu Skin enters research agreements
This article was originally published in The Rose Sheet
Executive Summary
Direct seller of anti-aging products has entered into research agreements with Stanford University and Madison, Wis.-based LifeGen Technologies to improve its understanding of the genetic basis of aging. In an Oct. 22 release, the firm says its agreement with Stanford "aims to increase the understanding of fundamental aging mechanisms" and includes access to the university's expertise in dermatological clinical trials. The exclusive agreement with LifeGen will "leverage LifeGen's proprietary methods regarding gene expression profiling and pathways affected by aging." The relationships will "help us develop next-generation skin care and nutritional products," says Joseph Chang, Nu Skin chief scientific officer and executive VP of product development. Provo, Utah-based Nu Skin sells its personal-care products - including cosmetics, hair care and fragrances - in 48 international markets through more than 750,000 independent sales representatives. In 2010, it plans to expand its ageLOC anti-aging line with nutritional supplements (1"The Rose Sheet" June 29, 2009)
You may also be interested in...
Nu Skin Secures Future In Genetics Of Aging With LifeGen Acquisition
Nu Skin’s acquisition of LifeGen Technologies for roughly $11.66 million will ensure that the direct seller’s anti-aging business continues to benefit from LifeGen’s research into the genetic basis for aging.
Nu Skin plans ageLOC expansion
Firm plans to extend its ageLOC offering with introduction of "an unmatched daily skin-care system" this October, according to June 22 release. A nutritional supplement will follow in the second half of 2010, Nu Skin says. Galvanic Spa Facial Gels with ageLOC technology, which targets a "source of internal aging [that] is capable of generating free radicals in the epidermis around the clock," launched in fall 2008. Announcement emerges from firm's international sales meeting in Saint Petersburg, Russia. "AgeLOC will not only have significant implications for an aging population that wants to live young, but also for an increasing number of people who are seeking out Nu Skin's business opportunity to supplement or replace their income," company says. With more than 750,000 independent sales reps in 48 international markets, direct seller notes that its distribution program is an "attractive option" for many in the current economy. By 2030, the world's population of people over the age of 60 is expected to double to more than 1 billion, according to Nu Skin, which "believe[s] that ageLOC is unlocking the secret of youth.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.